Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Market Intel: Orthobiologics Market Well-Positioned For Innovative Reconstruction

Aug 29 2017

• By Gayle Grimes

3d rendered medically accurate illustration of a runners bones

Related Content

US Ortho Extremities/Soft-Tissue Repair Market To Grow $2.2 Billion By 2019

Dec 17 2015

Wright Sees Potential $1B+ Market Opportunity With Newly-Approved Orthobiologic

Sep 29 2015

21st Century Cures Implementation: Device Provision Updates

Jun 20 2017

Market Intel: Market Dynamics Switchover To Come In Fast-Growing Soft Tissue Fixation Segment

May 09 2017

US FDA: 510(k)-Exempt Class II Devices Should Withdraw Applications

Jul 11 2017

Deals Shaping the Medical Industry, October 2016

Oct 10 2016

Related Companies

Arthrex, Inc.

Musculoskeletal Transplant Foundation, Inc.

Zimmer Biomet Holdings, Inc.

LifeNet Health

AlloSource

Vericel Corporation

Surgalign Holdings, Inc.

Wright Medical Group N.V.

Orthox Ltd.

Smith & Nephew plc

Anika Therapeutics, Inc.

BioTissue Technologies AG

CONMED Corp.

Osiris Therapeutics, Inc.

Takeda Pharmaceutical Co. Ltd.

Johnson & Johnson

Johnson & Johnson

Isto Biologics

B. Braun Melsungen AG

B. Braun Melsungen AG

BioTissue Technologies AG

Cartiva, Inc.

CartiHeal Ltd.

Histogenics Corporation

Mesoblast Limited

Kolon TissueGene, Inc.

Kolon Life Science, Inc.

Mundipharma International Limited

Surgalign Holdings, Inc.

Medtronic plc

Wright Medical Group N.V.

Additional Topics

Market Intelligence Commercial Orthopedics Cellular & Genetic Medical Device

More from Orthopedics

More from Device Area

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window